The Learning Portal will be under maintenance 6-7 December. Portal functionality may be unavailable intermittently during this window.
We apologize for any inconvenience caused during this time.

  • Regulatory NewsRegulatory News

    HHS Secretary Tom Price Resigns

    • 29 September 2017
    Friday afternoon, the White House announced the resignation of HHS Secretary Tom Price and his replacement of Don Wright as the acting secretary. His resignation follows numerous questions related to his use of private jets and their mounting cost to the US taxpayer. Politico first broke the story of Price’s use of the charter planes more than a week ago. Price, who was sworn in in February and was the former chairman of the House budget committee, served as secret...
  • Regulatory NewsRegulatory News

    HHS Secretary Pushes to Cut FDA Appropriations, Replace With More Industry Fees

    Secretary of Health and Human Services (HHS) Tom Price is continuing to push the Senate to further increase the industry fees paid to the US Food and Drug Administration (FDA), which would upend the agreed-to amounts negotiated by FDA and industry for the next five years, and allow for further cuts to the agency’s congressional appropriations. Last week, the Senate Health, Education, Labor & Pensions (HELP) committee advanced a bill reauthorizing the user fee pro...
  • Regulatory NewsRegulatory News

    Sen. Wyden to HHS: Upcoming FDA Opioid Meeting Full of Conflicts of Interest

    Sen. Ron Wyden (D-OR) is requesting that the US Food and Drug Administration (FDA) delay a workshop on opioids because of the financial conflicts between opioid manufacturers and those participating in the event, according to a letter sent Friday to HHS Secretary Tom Price. The workshop , set for Tuesday and Wednesday, is intended to obtain input on the issues and challenges associated with federal efforts to support training on pain management and the safe prescr...
  • Regulatory NewsRegulatory News

    Trump’s FDA Commissioner Choice Coming Soon

    Dr. Tom Price, secretary of the US Department of Health and Human Services, said in an interview this week that the new commissioner for the US Food and Drug Administration (FDA) and other health-related political appointees should be announced in the next week or so. Price, speaking on the Hugh Hewitt show on Monday, said : “I’ve got 18 Senate-approved, presidential-appointed, Senate-approved folks in my department, and we’ve got virtually all of them with names that ...
  • Regulatory NewsRegulatory News

    CDC, NIH 'Working Closely' With FDA on Zika Response

    At a Congressional hearing in Washington, DC on Wednesday, officials from the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) say they are working closely with the US Food and Drug Administration (FDA) in their response to the Zika virus. During the hearing, CDC Director Tom Frieden and Anthony Fauci, director of the National Institutes of Allergy and Infectious Disease (NIAID) briefed members of the House Foreign Affairs Committe...